Form 4: Guardant Health Director Tariq Musa Executes Stock Transactions

Director Tariq Musa of Guardant Health, Inc. engaged in stock transactions, including the sale of 2,320 shares and the vesting of 250 restricted stock units.

Summary

• Tariq Musa, a director at Guardant Health, Inc., sold 2,320 shares of common stock at $35 per share on December 13, 2024.
• On December 15, 2024, 250 restricted stock units vested, converting into 250 shares of common stock.
• Following these transactions, Musa directly owns 2,926 shares of common stock and 6,746 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of insider transactions, which is neither positive nor negative in itself. It reflects normal activity.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which is common for publicly traded companies like Guardant Health. These filings provide transparency into the trading activities of company directors and officers.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, as mandated by the Securities and Exchange Commission (SEC).
• The transactions reported are typical for directors who receive stock-based compensation and may periodically sell shares for personal financial management.
• The vesting schedule of the restricted stock units is a common practice for employee and director compensation in the tech and biotech industries.

Stakeholder Impact

• The transactions may have a minor impact on the stock price, but are generally considered routine insider activity.
• Shareholders are informed of the transactions by a company director.

Key Dates

Keywords

Guardant Health, stock transaction, Form 4, Tariq Musa, restricted stock units, insider trading, equity securities